MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Exploring Neuroprotective Role of Natural Compound by Targeting c-Abl Kinase in Parkinson’s Disease

    D. Khatri (Chandwaji, Jaipur, India)

    Objective: To explore c-Abl kinase activation and neuron death pathway in Parkinson’s Disease (PD) mouse model. Assess neuroprotection natural compounds, Rosmarinic acid (RA) with proven…
  • 2025 International Congress

    Sensory-motor striatum iron accumulation in patients with isolated rapid eye movement sleep behavior disorder and its correlation with processing speed performance

    C. Garcia-Vicente, I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, C. Junqué, A. Iranzo, B. Segura (Madrid, Spain)

    Objective: This study aims to examine iron deposition in striatum and substantia nigra pars compacta (SNc) functionally segmented in patients with isolated rapid eye movement…
  • 2025 International Congress

    MultiModal Transformer-Based Detection of Parkinson’s Disease in fMRI Extracted Time Series

    S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)

    Objective: Develop and evaluate a multimodal, transformer-based pipeline for detecting Parkinson’s disease (PD) from resting-state fMRI time series, aiming to expose short-lived neural connectivity disruptions…
  • 2025 International Congress

    STN Iron Content Correlates with DBS Efficacy in Parkinson’s Patients: a Preliminary Study

    G. Du, A. Snyder, J. Seemiller, L. Kong, P. Eslinger, J. Mcinerney, E. Farace, R. Mailman, X. Huang, S. de Jesus (Hersehy, USA)

    Objective: Evaluate the relationship between baseline iron levels in the subthalamic nucleus (STN) and their impact on motor function and dopaminergic medication needs after deep…
  • 2025 International Congress

    LRRK2 Polymorphisms and Associations with Parkinson’s Disease in Participants of East Asian, Southeast Asian, and European Descent

    S. Nguyen, R. Edillor, J. Ruiz-Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: To investigate the prevalence of LRRK2 polymorphisms, R1628P and G2019S, and their association with Parkinson’s Disease (PD) in cohorts of East Asian (EA), Southeast…
  • 2025 International Congress

    Interrogating GCase Activity in Human Monocytes Isolated from Parkinson’s Disease Patients Carrying the Asian LRRK2 G2385R and R1628P Variants

    TS. Toh, JW. Hor, SY. Lim, LC. Lit, AN. Khairul Anuar, CY. Lew, YW. Tay, JL. Lim, A. Ahmad-Annuar, K. Zeneviciute, D. Alessi, E. Sammler, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To compare Glucocerebrosidase-1 (GCase) activity in human monocytes of manifesting LRRK2 G2385R, R1628P, and double-variant carriers vs. idiopathic Parkinson’s disease (iPD) and healthy controls…
  • 2025 International Congress

    Insights into Genetic Counseling Recall and Clinical Trial Interest in PD GENEration

    S. Rao, M. Murray, L. Caboy, R. de Leon, L. Desnoyers, M. Dini, K. Ghosh Galvelis, J. Beck, R. Alcalay (Miami, USA)

    Objective: To assess the impact of participation in PD GENEration, a large-scale genetic and counseling study for Parkinson’s disease (PD). We evaluated the recall of…
  • 2025 International Congress

    Artificial Intelligence Unveils Genetic Etiologies in Parkinson’s Disease: Cases Clustered by Clinical Features

    G. Di Rauso, A. Ghibellini, F. Pirone, G. Franco, F. Arienti, E. Frattini, I. Trezzi, F. Cavallieri, L. Bononi, M. Gabbrielli, F. Valzania, E. Monfrini, A. Di Fonzo (Reggio Emilia, Italy)

    Objective: The aim of this study is to explore whether artificial intelligence (AI) can accurately cluster Parkinson’s Disease (PD) patients carrying different variants in PD-associated…
  • 2025 International Congress

    Association Between Hyperuricemia, Gout, and the Risk of Parkinson’s Disease: An Updated Systematic Review and Meta-Analysis

    F. Qtaishat, J. Yasin, R. Odat, M. Alsufi, A. Abunamoos (Irbid, Jordan)

    Objective: To explore and evaluate the association between gout, hyperuricemia, and Parkinson’s disease (PD) using a systematic review and meta-analysis, incorporating stratified analyses by age…
  • 2025 International Congress

    Impact of rare lysosomal gene variants on Parkinson’s disease

    K. Senkevich, S. Parlar, C. Chantereault, L. Liu, E. Yu, U. Rudakou, J. Ruskey, J. Ahmad, F. Asayesh, D. Spiegelman, C. Waters, O. Monchi, Y. Dauvilliers, N. Dupré, L. Greenbaum, S. Hassin-Baer, I. Miliukhina, A. Timofeeva, A. Emelyanov, S. Pchelina, R. Alcalay, Z. Gan-Or (Montreal, Canada)

    Objective: To investigate the contribution of rare variants in lysosomal genes to Parkinson’s disease (PD) susceptibility. Background: Variants in the lysosomal gene GBA1 are established…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley